What does CUSIP 02043Q107 represent in this 13F holders report?

CUSIP 02043Q107 is the security identifier for ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK in Q3 2018?

297 institutional investors reported ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK for Q3 2018. Use the holders table for investor-level position and value details.

ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY)

CUSIP: 02043Q107

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class: Equity / COMMON STOCK
Shares outstanding: 133,095,681
Total 13F shares: 90,577,162
Share change: -893,837
Total reported value: $7,927,334,207
Put/Call ratio: 77%
Price per share: $87.52
Number of holders: 297
Value change: -$105,883,718
Number of buys: 141
Number of sells: 130

Quarterly Holders Quick Answers

What is CUSIP 02043Q107?
CUSIP 02043Q107 identifies ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2018
Previous quarter: Q2 2018

Recent filing periods for CUSIP 02043Q107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	11%	15,078,361	$1,485,068,000	—	30 Jun 2018	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	8.9%	11,784,320	$1,160,638,000	—	30 Jun 2018	13F
VANGUARD GROUP INC	13F	Company	5.7%	7,538,513	$742,468,000	—	30 Jun 2018	13F
BlackRock Finance, Inc.	13F	Company	4.6%	6,139,270	$604,654,000	—	30 Jun 2018	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	3.9%	5,213,963	$513,523,000	—	30 Jun 2018	13F
DODGE & COX	13F	Company	3.5%	4,654,701	$458,442,000	—	30 Jun 2018	13F
BAILLIE GIFFORD & CO	13F	Company	3.2%	4,231,881	$416,798,000	—	30 Jun 2018	13F
STATE STREET CORP	13F	Company	1.7%	2,250,242	$221,627,000	—	30 Jun 2018	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.4%	1,846,911	$181,902,000	—	30 Jun 2018	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	1%	1,358,599	$133,808,416	—	30 Jun 2018	13F
Point72 Asset Management, L.P.	13F	Company	1%	1,356,408	$133,593,000	—	30 Jun 2018	13F
ORBIMED ADVISORS LLC	13F	Company	0.95%	1,265,966	$124,685,000	—	30 Jun 2018	13F
MORGAN STANLEY	13F	Company	0.94%	1,257,041	$123,807,000	—	30 Jun 2018	13F
BB BIOTECH AG	13F	Company	0.86%	1,140,538	$112,332,000	—	30 Jun 2018	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.82%	1,094,716	$107,819,000	—	30 Jun 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.62%	828,899	$81,638,000	—	30 Jun 2018	13F
NORGES BANK	13F	Company	0.61%	818,236	$80,588,000	—	30 Jun 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.61%	806,745	$79,400,000	—	30 Jun 2018	13F
12 West Capital Management LP	13F	Company	0.55%	735,000	$72,390,000	—	30 Jun 2018	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.55%	734,335	$72,325,000	—	30 Jun 2018	13F
Avoro Capital Advisors LLC	13F	Company	0.53%	700,100	$68,953,000	—	30 Jun 2018	13F
MAVERICK CAPITAL LTD	13F	Company	0.51%	681,354	$67,107,000	—	30 Jun 2018	13F
FIRST TRUST ADVISORS LP	13F	Company	0.5%	659,766	$64,980,000	—	30 Jun 2018	13F
Artal Group S.A.	13F	Company	0.49%	650,000	$64,019,000	—	30 Jun 2018	13F
BRIDGER MANAGEMENT, LLC	13F	Company	0.48%	642,466	$63,276,000	—	30 Jun 2018	13F
JPMORGAN CHASE & CO	13F	Company	0.48%	633,052	$62,348,000	—	30 Jun 2018	13F
FEDERATED HERMES, INC.	13F	Company	0.45%	603,250	$59,414,000	—	30 Jun 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.41%	545,615	$53,737,000	—	30 Jun 2018	13F
Bank of New York Mellon Corp	13F	Company	0.38%	511,961	$50,423,000	—	30 Jun 2018	13F
NORTHERN TRUST CORP	13F	Company	0.37%	492,768	$48,533,000	—	30 Jun 2018	13F
Mitsubishi UFJ Trust & Banking Corp	13F	Company	0.36%	483,351	$47,605,000	—	30 Jun 2018	13F
Slate Path Capital LP	13F	Company	0.36%	480,000	$47,275,000	—	30 Jun 2018	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.32%	427,740	$42,128,000	—	30 Jun 2018	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.31%	415,000	$40,873,000	—	30 Jun 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.28%	375,400	$36,973,000	—	30 Jun 2018	13F
RTW INVESTMENTS, LP	13F	Company	0.26%	352,200	$34,688,000	—	30 Jun 2018	13F
Legal & General Group Plc	13F	Company	0.26%	340,511	$33,537,000	—	30 Jun 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.23%	304,233	$29,964,000	—	30 Jun 2018	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.23%	303,700	$29,911,000	—	30 Jun 2018	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.23%	302,695	$29,812,000	—	30 Jun 2018	13F
683 Capital Management, LLC	13F	Company	0.23%	300,000	$29,547,000	—	30 Jun 2018	13F
Swiss National Bank	13F	Company	0.22%	296,600	$29,212,000	—	30 Jun 2018	13F
TOBAM	13F	Company	0.22%	287,714	$28,337,000	—	30 Jun 2018	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	0.2%	271,295	$26,720,000	—	30 Jun 2018	13F
Casdin Capital, LLC	13F	Company	0.2%	270,000	$26,592,000	—	30 Jun 2018	13F
Rockefeller Capital Management L.P.	13F	Company	0.2%	268,111	$26,406,000	—	30 Jun 2018	13F
GREAT POINT PARTNERS LLC	13F	Company	0.2%	260,100	$25,617,000	—	30 Jun 2018	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.18%	245,716	$24,201,000	—	30 Jun 2018	13F
KORNITZER CAPITAL MANAGEMENT INC /KS	13F	Company	0.18%	244,144	$24,046,000	—	30 Jun 2018	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.18%	233,822	$23,029,000	—	30 Jun 2018	13F

Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q3 2018

As of 30 Sep 2018, ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) was held by 297 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 90,577,162 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Vanguard Group Inc, BlackRock Inc., DODGE & COX, BAILLIE GIFFORD & CO, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, MAVERICK CAPITAL LTD, and BB BIOTECH AG. This page lists 297 institutional shareholders reporting positions in this security for the Q3 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2018 vs Q2 2018 Across Filers

Q2 2018 holders

303

Q3 2018 holders

297

Holder diff

-6

Investor	Q2 2018 Shares	Q3 2018 Shares	Share Diff	Share Chg %	Q2 2018 Value $	Q3 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.